These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2836003)

  • 1. K562 cells produce and respond to human erythroid-potentiating activity.
    Avalos BR; Kaufman SE; Tomonaga M; Williams RE; Golde DW; Gasson JC
    Blood; 1988 Jun; 71(6):1720-5. PubMed ID: 2836003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562.
    Fraser JK; Lin FK; Berridge MV
    Blood; 1988 Jan; 71(1):104-9. PubMed ID: 2825843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells.
    Alitalo R; Partanen J; Pertovaara L; Hölttä E; Sistonen L; Andersson L; Alitalo K
    Blood; 1990 May; 75(10):1974-82. PubMed ID: 2159816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity.
    Westbrook CA; Gasson JC; Gerber SE; Selsted ME; Golde DW
    J Biol Chem; 1984 Aug; 259(16):9992-6. PubMed ID: 6332112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukemia cell line K562 responds to erythroid-potentiating activity.
    Gauwerky CE; Lusis AJ; Golde DW
    Blood; 1982 Feb; 59(2):300-5. PubMed ID: 6976809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of erythroid-potentiating activity by a human T-lymphoblast cell line.
    Golde DW; Bersch N; Quan SG; Lusis AJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):593-6. PubMed ID: 6987658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
    Feldman L; Frazier JG; Sytkowski AJ
    Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity.
    Gasson JC; Golde DW; Kaufman SE; Westbrook CA; Hewick RM; Kaufman RJ; Wong GG; Temple PA; Leary AC; Brown EL
    Nature; 1985 Jun 27-Jul 3; 315(6022):768-71. PubMed ID: 3839290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducers of erythroid differentiation in K562 human leukemia cells.
    Rowley PT; Ohlsson-Wilhelm BM; Farley BA; LaBella S
    Exp Hematol; 1981 Jan; 9(1):32-7. PubMed ID: 6940756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid-potentiating activity: characterization and target cells.
    Gauwerky CE; Lusis AJ; Golde DW
    Exp Hematol; 1980; 8 Suppl 8():117-27. PubMed ID: 6984393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of purified human erythroid-potentiating activity.
    Gasson JC; Bersch N; Golde DW
    Prog Clin Biol Res; 1985; 184():95-104. PubMed ID: 3931094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells.
    Amagasaki T; Green R; Jacobsen DW
    Blood; 1990 Oct; 76(7):1380-6. PubMed ID: 2169922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal effects on cell proliferation in a human erythroleukemia cell line (K562).
    Gauwerky C; Golde DW
    Blood; 1980 Nov; 56(5):886-91. PubMed ID: 6932980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid-potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment.
    Hayakawa T; Yamashita K; Kishi J; Harigaya K
    FEBS Lett; 1990 Jul; 268(1):125-8. PubMed ID: 2166680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity.
    Stetler-Stevenson WG; Bersch N; Golde DW
    FEBS Lett; 1992 Jan; 296(2):231-4. PubMed ID: 1370805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for erythropoietin in mouse and human erythroid cells and placenta.
    Sawyer ST; Krantz SB; Sawada K
    Blood; 1989 Jul; 74(1):103-9. PubMed ID: 2546618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line.
    Dupuis F; Levasseur S; Jean-Louis F; Dulery C; Praloran V; Denizot Y; Michel L
    Biochim Biophys Acta; 1997 Dec; 1359(3):241-9. PubMed ID: 9434130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of granulocyte-macrophage colony-stimulating factor and erythropoietin on leukemic erythroid colony formation in human early erythroblastic leukemias.
    Mitjavila MT; Villeval JL; Cramer P; Henri A; Gasson J; Krystal G; Tulliez M; Berger R; Breton-Gorius J; Vainchenker W
    Blood; 1987 Oct; 70(4):965-73. PubMed ID: 3498522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.